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Abstract
Background: Bright blood late gadolinium enhancement (LGE) imaging typically achieves excellent contrast
between infarcted and normal myocardium. However, the contrast between the myocardial infarction (MI) and the
blood pool is frequently suboptimal. A large fraction of infarctions caused by coronary artery disease are sub-
endocardial and thus adjacent to the blood pool. It is not infrequent that sub-endocardial MIs are difficult to detect
or clearly delineate.
Methods: In this present work, an inversion recovery (IR) T2 preparation was combined with single shot steady state
free precession imaging and respiratory motion corrected averaging to achieve dark blood LGE images with good
signal to noise ratio while maintaining the desired spatial and temporal resolution. In this manner, imaging was
conducted free-breathing, which has benefits for image quality, patient comfort, and clinical workflow in both adults
and children. Furthermore, by using a phase sensitive inversion recovery reconstruction the blood signal may be made
darker than the myocardium (i.e., negative signal values) thereby providing contrast between the blood and both the
MI and remote myocardium. In the proposed approach, a single T1-map scout was used to measure the myocardial
and blood T1 using a MOdified Look-Locker Inversion recovery (MOLLI) protocol and all protocol parameters were
automatically calculated from these values within the sequence thereby simplifying the user interface.
Results: The contrast to noise ratio (CNR) between MI and remote myocardium was measured in n = 30 subjects with
subendocardial MI using both bright blood and dark blood protocols. The CNR for the dark blood protocol had a 13 %
loss compared to the bright blood protocol. The CNR between the MI and blood pool was positive for all dark blood
cases, and was negative in 63 % of the bright blood cases. The conspicuity of subendocardial fibrosis and MI was
greatly improved by dark blood (DB) PSIR as well as the delineation of the subendocardial border.
Conclusions: Free-breathing, dark blood PSIR LGE imaging was demonstrated to improve the visualization of
subendocardial MI and fibrosis in cases with low contrast with adjacent blood pool. The proposed method also
improves visualization of thin walled fibrous structures such as atrial walls and valves, as well as papillary muscles.
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Background
Late gadolinium enhancement (LGE) has become a gold
standard in myocardial viability assessment [1, 2] provid-
ing excellent depiction of myocardial infarction (MI) and
macroscopic scarring. The use of late enhancement in
the diagnosis of ischemic heart disease and in guiding
therapy such as revascularization has gained wide
acceptance. More recently, late enhancement is playing a
broader role in characterizing fibrosis in non-ischemic
cardiomyopathies [3, 4], and in measurement of scar
resulting from treatment of cardiac arrhythmias using
radiofrequency ablation [5]. As the use of late enhance-
ment imaging has matured and as the span of
applications has widened, clinicians are examining late
enhancement images for more subtle indication of fibro-
sis and the demands on image quality have grown [6].
Late-enhancement imaging typically achieves excellent
contrast between infarcted and normal myocardium.
However, the contrast between the MI and the blood pool
is frequently suboptimal. A large fraction of infarctions
caused by coronary artery disease are sub-endocardial and
thus adjacent to the blood pool. The contrast between the
blood and MI in the inversion recovery (IR) image
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depends on variables such as contrast agent dosage, time
from gadolinium administration, clearance rate, and im-
aging parameters. Blood velocity may also have a role in
the contrast, even though non-slice-selective IR is used.
Therefore, as a result of mechanisms that are not fully
characterized or controlled, it is not infrequent that sub-
endocardial MIs are difficult to detect or clearly delineate.
Imaging at a later time point can result in better blood
pool contrast for some subjects, but it may not be prac-
tical from the stand point of clinical workflow to wait
too long, and in some instances contrast may worsen.
Technical solutions to this problem are to use multiple
contrasts such as T1 and T2 [7, 8], or to use blood sup-
pression techniques [9–15]. The T2 of blood (250 ms) is
significantly longer than that of myocardium (45 ms)
and may be used to discriminate the MI from blood
pool. In the “Multi-contrast delayed enhancement”
(MCODE) approach [6, 7, 16], both T1-and T2-weighted
images are acquired within the same breath-hold. The
T1-weighted image is a phase sensitive inversion recov-
ery (PSIR) image, and the T2-weighted image uses an RF
preparation for T2-weighting. Both images are acquired
at the same diastolic cardiac phase and are spatially
registered facilitating fusion of the images to enhance
the sub-endocardial border. An alternative approach that
also exploits the difference in tissue T1 and T2 is to use
a segmented cine IR with steady state free precession
(SSFP) readout [8]. In this method, each cardiac phase
has a unique T1 and T2 contrast as determined by both
the inversion recovery and the SSFP readout which has a
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
T2=T1
p
steady state dependence. The blood will ap-
pear dark at a different cardiac phase than the MI. In an
alternative approach a IR fast low angle shot (FLASH)
sequence may be modified to null both the blood and
the normal myocardium using 2 inversions with care-
fully chosen inversion times [10] or using a triple inver-
sion scheme [14].
Alternatively, LGE with blood suppression may be
achieve my combining either a T2 preparation [9, 11, 13]
with IR or by combining a magnetization transfer (MT)
preparation with IR [12, 15]. In these schemes, the
myocardial signal is reduced relative to the blood signal
thereby reducing the inversion times to null the myocar-
dium. In this way, it is possible to null both the myocar-
dium and the blood at the same time. The order of the T2
and IR preparations may be applied as T2-IR [13] or IR-
T2 [9]. Both of these previously reported schemes used a
FLASH readout. In this present work, we combined a
IR-T2 with a single shot SSFP readout and respiratory
motion corrected averaging [6, 17, 18] to achieve the
acceptable SNR while maintaining the desired spatial and
temporal resolution. In this manner, imaging is conducted
free-breathing which has benefits for image quality,
patient comfort, and clinical workflow in both adults [19]
and children [20]. Furthermore, by using a PSIR recon-
struction [21] the blood signal may be made darker than
the myocardium (i.e., negative signal values) thereby pro-
viding contrast between the blood and both the MI and
remote myocardium.
In conventional bright blood LGE, the contrast-to-noise
ratio for detection of scar is optimized by nulling the nor-
mal myocardium [22]. Selection of the inversion time (TI)
may be performed manually, or aided by a IR-cine scout
[23]. For dark blood (DB) LGE methods such as T2-IR,
IR-T2, or MT-IR, there are more degrees of freedom and
additional imaging protocol parameters must be specified
to achieve the desired myocardial null and blood signal
contrast. In the proposed approach, a single T1-map scout
is used to measure the myocardial and blood T1 using a
MOdified Look-Locker Inversion recovery (MOLLI)
protocol [24] and all protocol parameters are automatic-
ally calculated from these values within the sequence
thereby simplifying the user interface and avoiding the
necessity of a lengthy scout sequence. The use of PSIR
further avoids the requirement for precise nulling [6].
Dark blood LGE schemes provide contrast between the
MI and the blood pool at the expense of SNR. The SNR
cost of the proposed imaging method is characterized
through simulation and verified experimentally. It is pos-
sible to recover lost SNR by means of respiratory motion
corrected averaging with free breathing acquisition.
The proposed dark blood PSIR LGE is demonstrated for
several applications. One application, which motivated the
initial development, was peri-procedural cardiovascu-
lar MR in children undergoing radiofrequency catheter
ablation for ventricular tachycardia (VT). The concern
was the potential poor contrast with the adjacent blood
pool for acute subendocardial lesions. Patients undergoing
such procedures are anesthetized and all imaging should
ideally be acquired under free-breathing conditions.
Furthermore, imaging had to be performed rapidly. The
dark blood method was also used for LGE on subjects
with both ischemic and non-ischemic heart disease in
both adult and paediatric populations.
Methods
Dark-blood PSIR LGE
Dark Blood (DB) LGE was implemented by adding a T2
prep between the IR preparation and the readout [9].
This shifts the null time of the myocardium relative to
blood making it possible to choose delays that simultan-
eously null both myocardium and blood. Figure 1 illus-
trates the case where the intensity of the inversion
recovery signal for the scar is less than the blood leading
to poor contrast for conventional LGE (Fig. 1 (a)). By
addition of a T2 preparation (Fig. 1 (b)) and judicious
choice of delays a positive contrast between both the
scar and normal myocardium with the blood is achieved.
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In this example, the choice of delay parameters (TD1,
TE, and TD2) for the IR-T2 preparation are chosen to
null the normal myocardium prior to the blood which
makes the blood signal negative when reconstructed
using a phase sensitive approach (PSIR), and thus will
appear darker than the myocardium. Contrast between
the normal myocardium and blood is important in order
to delineate the myocardium wall.
With the IR-T2 approach to DB LGE, the myocardium
signal is attenuated to achieve an earlier null time.
Although blood suppression improves the contrast-to-
noise ratio (CNR) between MI and blood, the myocardial
signal attenuation corresponding to the T2 weighting
exp (−TE/T2) causes a loss in CNR between the MI and
remote normal myocardium as seen in Fig. 1. In the
proposed method, free-breathing PSIR LGE imaging was
performed using a single shot SSFP sequence with
respiratory motion correction (MOCO) averaging of re-
peated measurements [6, 17, 18]. The number of
averages was double for the dark blood protocol as
compared to the bright blood PSIR MOCO protocol in
order to improve the CNR by
ﬃﬃﬃ
2
p
, and thereby recover
some of the loss due to the T2 weighting.
The MOCO is done independently for the IR and proton
density (PD) images and the MOCO averaged images are
co-registered prior to the PSIR demodulation step. A non-
rigid image registration is used for in-plane motion correc-
tion and PD/IR co-registration, and in-plane motion is dealt
with by discarding 50 % of the acquired measurements
which are most dissimilar. Non-rigid registration was per-
formed pairwise between a target and reference image. For
each pair, the algorithm estimates a deformation that maxi-
mizes the local cross-correlation between the reference and
the uncorrected (target) image using a fast variational ap-
proach [25, 26] that can be considered as an extension of
the classic optical flow method. The process is imple-
mented in a multi-scale approach from coarse to fine reso-
lution which increases the speed and provides improved
convergence. Once the non-rigid motion (deformation)
field is estimated, the images are warped using a sub-pixel
spline based interpolator. The selection of the reference
frame used for image registration as well as which frames
to be discarded is based on the similarity of frames as esti-
mated from a global mean square difference metric [17]. In
this way, the retrospective image based strategy averages
the most frequent respiratory phase which is typically at
Fig. 1 a inversion recovery for bright blood PSIR LGE in case with scar signal (blue) less than blood (red) resulting in poor contrast. b inversion
recovery for Dark Blood (DB) PSIR using combined IR and T2 preparation to shift the null time of blood relative to the normal myocardium. In
this case the delays are chosen such that the blood signal (red) is less than the myocardium (dashed gray) resulting in dark blood using PSIR
reconstruction, which preserves the signal polarity. Inversion times to null the normal myocardium are depicted by vertical dashed lines. The loss
in SNR due to the T2 preparation is mitigated by increased respiratory motion corrected averaging (MOCO)
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end-expiration. The image reconstruction pipeline was im-
plemented and deployed using the Gadgetron image recon-
struction framework [27].
Unlike the conventional PSIR LGE, which has a single
inversion time parameter (TI) to specify in order to null
the normal myocardium, the DB PSIR LGE has 3 param-
eters, TD1, TE, and TD2. In order to facilitate the
selection these parameters, a complete Bloch simulation
was performed using the complete imaging protocol,
patient heart rate, measured T1 values of the remote
normal myocardium and blood pool, and assuming nom-
inal values for myocardial T2 (45 ms) and blood T2
(250 ms). The simulation determined the delay times TD1
and TD2 which null either the myocardium or blood for a
given T2 prep echo time (TE) by calculating the
magnetization for each readout of the inversion recovery
signal. The calculated null times are shown in Fig. 2 for an
example protocol (T1myo = 500 ms, T1blood = 350 ms) with
null times for blood in red and myocardium in blue for a
set of TE’s. For TE = 20 ms, the red and blue curves inter-
sect at TD1 = 63 ms and TD2 = 38 ms. At this intersection,
TD1 = 63/TD2 = 38/TE = 20, the normal myocardium and
blood are simultaneously nulled. For this TE (20 ms) and
for points on the blue line with TD2 > 38 ms, the myocar-
dium is nulled and the blood will have negative values (i.e.,
not recovered past zero) and will appear dark with respect
to the normal myocardium, and for TD < 38 the myocar-
dium will have a positive signal. For TE ≥ 25 ms, the blood
will be dark, in this example, and for TE <20 will appear
bright. The spacing between the blue and red lines will
govern the degree of blood suppression.
Typical imaging parameters are listed in Table 1 for both
the bright and dark blood PSIR MOCO protocols. The
myocardial and blood T1 are measured using a T1-
mapping scout scan using the MOdified Look-Locker In-
version recovery (MOLLI) approach [24] with a modified
protocol using respiratory motion correction and a 4 s (1 s)
3 s (1 s) 2 s acquisition scheme [28] that is acquired in 11 s.
The measured T1 values are entered on the scanner in the
user interface (UI) (shown in Fig. 3). The blood suppression
is specified as a value (delta) which is dark when the value
delta < 0. The sequence calculates TD1, TD2, and TE using
a strategy that seeks to achieve the desired blood suppres-
sion with the shortest TE so as to minimize SNR loss. In
order to speed up the computation, a series of rotation
matrices were pre-computed and stored as look-up-tables
(LUT). In this way, the calculation was fast enough that the
user interface was responsive to changes in imaging proto-
col parameters. The values for TD1, TD2, and TE are
thereby updated on the fly when any protocol parameter is
modified (e.g., matrix size, flip angle, etc.).
The Bloch simulation used to generate the LUTs
included a waveform level calculation of the adiabatic
T2 prep and hypersecant inversion pulses as well as
shape of RF excitation pulses, which determine the slice
profile. The T2 prep was a custom design 0° BIR4 with
single refocusing pulse capable of achieving TE as short
as 10 ms.
Fig. 2 Calculation of delays TD1 and TD2 for various TE for specified myocardial and blood T1 of 500 ms and 350 ms respectively. TD1 and TD2
are calculated to null the normal myocardium (point on blue line) to achieve a specified blood suppression. In this case, dark blood may be
achieved for TE≥ 20 ms. The spacing between the blue (myocardial null) and red (blood null) indicated the degree of blood suppression with
dark blood (blood <myocardium) when red line is above the blue line. Calculations are performed interactively on the scanner in response to
protocol changes (TR, FA, matrix size, etc.)
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In-vivo studies
In-vivo studies were performed to validate the concept,
measure the performance, and evaluate the user interface
in a clinical workflow. To meet this objective, a pilot study
was performed at 4 sites: Children’s National Medical
Center (CNMC), Washington, D.C., Bart’s Heart Centre, St.
Barthomolew’s Hospital, London, UK, The National Amyl-
oidosis Centre, UCL Royal Free Hospital, London, UK, and
Karolinska University Hospital, Stockholm, Sweden. Studies
were approved by the local Ethics Committees and Internal
Review Boards at each institution. Data was acquired for 61
subjects (Bart’s 39, Karolinska 9, Royal Free 9, CNMC 4).
Initial data was used to optimize the protocol parameters
(number of averages and blood suppression “delta” param-
eter). After initial protocol optimization, raw data was saved
to facilitate SNR measurement. CNR measurements were
made on 30 subjects (Bart’s 21, Karolinska 5, Royal Free 4)
with clearly identifiable MI. Anonymized data was analysed
at NIH with approval by the NIH Office of Human Subjects
Research OHSR (Exemption #13156). All imaging was
performed at 1.5 T (Magnetom AERA, Siemens, software
version VE11A). Gadolinium (Gd) contrast agent (Gadobu-
trol or Gadoterate meglumine) and dosage (0.1-0.2 mmol/
kg) varied between sites. LGE images were acquired
between 10–20 min following administration of Gd con-
trast. In this initial technical development study, both dark
blood and bright blood PSIR LGE MOCO imaging was
performed at the end of the study for all consented subjects
for which the additional time could be accommodated in
the clinical workflow at the discretion of the radiographer
performing the scan. At the completion of bright blood
PSIR imaging the dark blood imaging was performed for a
single slice, followed by a repeated bright blood PSIR
MOCO LGE. Both the dark blood and bright blood images
analysed were acquired within 1 min. The acquisition
duration for the bright blood approach was 16 heart beats
Table 1 Imaging protocol parameters
Bright Blood (BB) Dark Blood (DB)
Preparation Inversion
Preparation
Inversion Preparation
& T2 preparation
Readout Single shot, SSFP
(FAIR = 50°, FA PD = 8°)
Typical FOV/resolution 360 × 270 mm2
1.4 × 1.9 × 8 mm3
Matrix size 256 × 144 (parallel imaging factor 2)
Number of acquired
measurements
8 16
T2 prep TE 10–40 ms
TE/TR 1.2/2.8 ms
ECG triggering Inversions every 2 RR (HR < 90 bpm)
Inversions every 3 RR (HR > 90 bpm)
Fig. 3 User Interface for Dark Blood (DB) Protocol: (1) User acquires T1 map and measures ROI values for remote blood and myocardium. (2) a
enter ROI values in sequence user interface, b enter degree of blood suppression as “delta” value in user interface. (All other parameters (TE, TD1,
TD2) are calculated automatically). (3) Acquire images free-breathing
Kellman et al. Journal of Cardiovascular Magnetic Resonance  (2016) 18:77 Page 5 of 11
per slice (8 measurements × 2 RR) and for the dark blood
approach was 32 heart beats (16 measurements).
CNR Measurements
The contrast-to-noise ratios (CNR) of interest are the dif-
ference of SNR between MI and remote (CNRMI-remote),
between MI and blood pool (CNRMI-blood), and between
blood and remote (CNRblood-remote). CNR measurements
were made by subtracting the SNR from manually drawn
regions of interest on SNR scaled image reconstructions
[29, 30]. SNR scaled uniform noise, PSIR MOCO average
images prior to surface coil correction were used. This
method accounts for all factors including the parallel
imaging losses due to so-called g-factor. Measurements
were made on N = 30 studies for which there was positive
identification of scar.
Results
CNR measurements
The CNRMI-remote for dark blood (DB) and bright blood
(BB) protocols in Table 1 were measured for N = 30
patients (Fig. 4). The CNR between MI and remote
myocardium using the 2 protocols had a linear fit DB-
CNRMI-remote = 0.87 BB-CNRMI-remote + 0.38 correspond-
ing to a 13 % loss in CNR for the dark blood protocol
(95 % confidence of slope was 0.76 to 0.98). Using the
dark blood PSIR LGE protocol, the contrast between the
MI and blood (CNRMI-blood) was positive for all cases,
whereas a significant fraction (63 %) of the conventional
bright blood PSIR cases have poor contrast between the
MI and blood (CNRMI-blood < 0) as region shaded in gray.
The CNR between the blood and remote myocardium
was 17.4 ± 7.1 (m ± SD) for the bright blood protocol,
and−3.9 ± 3.2 for the dark blood protocol.
Example studies
The degree of blood suppression may be varied by adjust-
ing the user specified “delta” parameter on the sequence
user interface (Fig. 5). The “delta” parameter was +20, +5,
and−15 ms (from left to right) for the 3 blood suppressed
images. The inferior MI (long arrows) is most clearly de-
fined with the blood suppression set for dark blood (right)
Fig. 4 CNR measurements between MI and remote (left) and MI and blood pool (right) for N = 30 patients. Note that using the dark blood PSIR
LGE the contrast between the MI and blood (CNRMI-blood) is positive for all cases, whereas a large number of conventional bright blood PSIR have
poor contrast between the MI and blood (CNRMI-blood < 0) as region shaded in gray
Fig. 5 Bright blood PSIR LGE (left) and dark blood PSIR LGE with varying blood suppression. The subendocardial MI (long arrow) has increasing
contrast with the blood pool as the blood suppression is increased. Gibb’s ringing (short arrow) of LV blood pool at septal border in bright blood
LGE (left) is not present in DB LGE
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which is used by default. Slight Gibb’s ringing of the LV
blood pool observed in the septal region (short arrows) for
the bright blood PSIR LGE image which may mimic LGE
is clearly not evident in the blood suppressed images.
Examples of PSIR LGE positive cases by both bright and
dark blood methods are shown in Fig. 6 for a series of
studies. The areas of scar indicated by LGE are more
conspicuous on the DB PSIR images (see arrows) and in
some cases might have been missed entirely in the bright
blood PSIR images. Although an MI is clearly present in
Fig. 6 middle row right, multi-vessel involvement seen in
the DB PSIR image is difficult to assess in the bright blood
image. LGE in papillary muscles has positive contrast in
the DB PSIR. In the case with amyloidosis (Fig. 6 lower
right), subendocardial fibrosis appears more distinct in the
DB PSIR image, particularly in LV. In Fig. 7 is an example
of a case (7 year old male with dilated cardiomyopathy) in
which the dark blood PSIR LGE (right) suppressed a
bright signal in the myocardium on the bright blood PSIR
LGE, which could have been erroneously classified as a
lesion, but turned out to be due to blood trapped in
trabeculae. There is also Gibb’s ringing of the LV blood
pool in the septum region for the bright blood LGE image.
The PSIR LGE images in Fig. 8 are from a VT ablation
case. Free-breathing PSIR MOCO LGE was acquired
immediately following ablation in a 2 year old male (top
row) and at a 2 week follow-up study for a 14 year old
female (bottom row). Figure 9 illustrates the improvement
in visualization of thin wall structures such as atrial walls
and valves.
Discussion
The conspicuity of subendocardial fibrosis and MI is
greatly improved by dark blood (DB) PSIR as well as the
delineation of the subendocardial border. Dark blood PSIR
also improves the detection of LGE in papillary muscles
and thin wall structures such as atria and valves. In several
cases, the circumferential extent of the scar appears
Fig. 6 Example of bright and dark blood PSIR LGE for 6 adult patient studies with subendocardial LGE
Fig. 7 Example of dark blood PSIR LGE (right) showing that a
possible lateral infarct on the bright blood (left) is in fact just blood
pool signal in the trabeculae
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underestimated by bright blood LGE since a portion of
the MI had poor contrast with the blood pool. It is also
challenging to accurately measure the transmurality of
subendocardial MI using bright blood LGE in cases where
the subendocardial border is cannot be delineated.
Atrial walls and valves are thin walled fibrous struc-
tures with higher collagen fraction resulting in higher
gadolinium concentration and shorter T1, which thereby
null at shorter TI. These structures may be difficult to
resolve from the adjacent blood pool using bright blood
LGE but are more readily detected using the dark blood
approach (Fig. 9). In order to detect atrial fibrosis, it
may be necessary to adjust the displayed window and
level or to acquire images with the T1 value adjusted to
a lower value than the myocardium in order to null the
atrial wall for better visualization of atrial scar. This is
an area of future investigation.
Dark blood PSIR LGE is typically reconstructed with a
negative blood pool signal which, after windowing, appears
darker than the remote normal myocardium. The normal
remote myocardium is acquired at or close to the null point
and should be near zero. Since the displayed image is
always positive, contrast between the normal myocardium
and blood is achieved by setting the display window width
and level to bias the myocardium to be slightly positive.
The bias should be kept small such that the apparent
contrast enhancement ration (CER) between the MI and
remote normal myocardium is kept adequately high.
Fig. 8 Free-breathing PSIR MOCO LGE acquired immediately following ablation in subject 1 under sedation (2 year old male) using bright blood
(left) and dark blood (right) protocols shows acute ablation lesion (top row) and subject 2 (14 year old female) in 2-week follow-up study with ab-
lation lesion in LV septum (bottom row)
Fig. 9 PSIR LGE images in 3 chamber view illustrating the improved visualization of thin walled atria and valve structures using DB (right). Note
that the thin walled structures have greater enhancement than the myocardium due to fibrous composition leading to higher gadolinium
concentration with shorter T1 than myocardium
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CNR Measurement
The CNRMI-remote for the dark blood protocol was slightly
less than for the bright blood protocol as expected due to
the T2 weighting. The expected loss is approximately exp
(−TE/T2)*
ﬃﬃﬃ
2
p
since the dark blood protocol averaged
double the measurements (16 vs 8). The TE is picked by
the sequence to achieve the desired blood suppression.
The measured loss of 13 % is consistent with a TE
between 20–25 ms. It is difficult to delineate the subendo-
cardial border for bright blood LGE as illustrated in Fig. 10.
Signal intensity profiles thru the MI and blood (Fig. 10)
are in SNR units and the subendocardial MI is 1–2 pixels
width. It is possible to measure the width of the MI using
full-width half maximum criteria for mitigating partial
volume effects using the DB PSIR LGE, however this is
not possible for the bright blood image.
Limitations
The proposed dark blood PSIR LGE method uses an
IR-T2 preparation and has a minimum delay time due to
the duration of the T2 prep. Therefore, for high contrast
doses that result in very short T1 it may not be possible
to achieve a short enough delay. In these cases, the
degree of blood suppression specified may not be
achievable. The sequence will attempt to reach the
desired blood suppression specified by the delta param-
eter and if that is not possible will then try to reduce the
blood suppression until a solution is achieved.
The loss in CNR is compensated for by increasing the
averaging. Roughly double the time is required to
achieve the same performance as the bright blood PSIR
MOCO. For a short axis stack of 9-slices, this acquisi-
tion time is roughly 5 min for dark blood vs 2.5 min for
bright blood. This imposes a limitation on the clinical
workflow, although it is comparable to some breath-held
acquisitions. The user interface for the dark blood PSIR
requires a T1 mapping scout and entry of T1 values
from roughly measured ROIs in the myocardium and LV
blood pool. This process is fairly quick (<1 min) but is
an added level of complexity in the clinical workflow.
The display of dark blood PSIR images requires win-
dow levelling the PSIR image so that the blood is darker
than the normal myocardium. This equates to making
the normal myocardium slightly gray (elevated) even
though the myocardium may in fact be nulled. Detection
of subtle LGE may require careful adjustment of the
window level subtle and experience to gain confidence
in interpretation.
In this study, the T1 value of blood measured in the
MOLLI scout used for setting the protocol is based on a
ROI drawn in the left ventricular (LV) cavity. Since the
deoxygenated blood of the right ventricular (RV) cavity
has T1 that is shorter than the LV blood (typically 150
vs 250 ms), the RV blood pool will have a slight attenu-
ation by the T2 prep and will null slightly earlier. As a
result, the RV blood pool suppression will be less than
the LV blood. In general, the RV blood was suppressed
to provide adequately contrast, and it is possible to
further reduce the RV blood signal by increasing the
suppression parameter.
The measurement of bright and dark blood PSIR LGE
were performed within 1 min, however the order of
sampling was not randomized in this study. The contrast
does not change significantly during 1 min so it felt that
any bias in measurement of contrast would not alter the
overall conclusion.
Conclusions
Free-breathing, dark blood PSIR LGE imaging has been
demonstrated to improve the visualization of subendo-
cardial MI and fibrosis in cases with low contrast with
adjacent blood pool. The proposed method also im-
proves visualization of thin walled fibrous structures
such as atrial walls and valves, as well as papillary mus-
cles. Imaging parameters are calculated automatically
based on a single scout scan.
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